Teva Pharmaceutical Industries $4.5 billion senior notes issues

Value:

$ 4.5 billion

Status:

Announced

Date:

14/3/2018

Teva Pharmaceutical Industries has issued $4.5 billion in senior notes.
The issue consists of $1.25 billion 6% senior notes due 2024, $1.25 billion 6.75% senior notes due 2028, €700 million 3.25% senior notes due 2022 and €900 million 4.5% senior notes due 2025.
Barclays, BofA Merrill Lynch, BNP Paribas, Citigroup, Credit Suisse and HSBC acted as initial purchasers.

United States
Netherlands
United Kingdom
Israel

High-yield bond/note issue

Capital markets : Debt

Pharmaceuticals and life sciences

Cleary Gottlieb Steen & Hamilton

Party: Barclays (Initial purchaser)

Party: Bank of America Merrill Lynch (Initial purchaser)

Party: BNP Paribas (Initial purchaser)

Party: Citigroup (Initial purchaser)

Party: Credit Suisse (Initial purchaser)

Party: HSBC (Initial purchaser)

Lawyer: David Gottlieb